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Abstract: The EGF receptor (HER1/EGFR) and its cognate ligands are of considerable interest in epidermal biology and 
pathology. HER1/EGFR is expressed throughout the entire epidermis and its signaling has been shown involved in the 
control of keratinocyte proliferation, adhesion, and differentiation. The signaling of HER1/EGFR can be modulated by the 
receptor’s immediate environment, particularly by its localization or not of lipid rafts. These membrane domains are 
nowadays described as heterogeneous dynamic signaling platforms where lipid molecules, cholesterol especially, are 
highly ordered and where transmembrane proteins encounter a specialized environment. Cholesterol depletion has been 
used in order to disorganize lipid rafts in keratinocytes and induces activation of HER1/EGFR (without ligand addition), 
as well as downstream signaling. The activation of p38 MAPK obtained after cholesterol depletion is responsible for the 
induction of involucrin expression while keratin expression is suppressed. However in keratinocytes recovering from 
cholesterol depletion the activation of p38 MAPK induces a strong expression of the heparin-binding EGF-like growth 
factor, a ligand of HER1/EGFR. Lipid rafts could thus be membrane platforms that regulate cell signaling in keratinocytes 
in normal, but also pathological conditions. 
1. INTRODUCTION 
 Growth factors of the epidermal growth factor (EGF) 
family demonstrate high potency in the control of epidermal 
keratinocytes in normal skin and in diseases. This control 
works through the EGF receptor (EGFR) also named Human 
EGF Receptor 1 (HER1), the integral protein that binds 
members of the EGF family on its extracellular moiety and 
exhibits ligand-induced tyrosine kinase activity in its 
cytoplasmic domain. The function of HER1/EGFR can be 
regulated by its molecular environment in the plasma 
membrane. In the present chapter, we will depict important 
functions played by HER1/EGFR in epidermal keratinocytes 
and how lipid rafts, specialized domains of the plasma 
membrane, influence HER1/EGFR functioning in general, 
but also in the epidermal context where lipid rafts can 
modulate the epidermal phenotype. 
2. IMPORTANCE OF THE EGF RECEPTOR IN THE 
PHYSIOLOGY OF KERATINOCYTES 
 The growth factor receptors relay through the plasma 
membrane crucial information brought by the release of 
ligands in the cell surrounding, creating intracellular signals 
intended to regulate critical cellular functions. Among those 
receptors, the epidermal growth factor (EGF) receptor family 
of receptors is named the human EGF receptor (HER) family 
in the human species and its members result from the 
transcription of the different ErbB genes. The EGF receptor 
acts on major and disparate cellular functions such as cell  
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proliferation, motility, adhesion and differentiation. For 
instance, EGF was named originally as epidermal due to its 
ability to stimulate proliferation of murine epidermal cells in 
the pioneering work of Cohen (for a historical review, see 
[1]). Consequently, there has been considerable interest for 
the HER family and for their ligands in the epidermal tissue 
as this system can control several epidermal functions. Thus, 
the members of the human EGF receptors family numbered 
HER1, HER2 and HER3, have been found expressed in 
human epidermal keratinocytes in vitro, as well as in vivo. In 
human skin, the HER1/EGFR is predominant and localized 
throughout the entire epidermis, although its expression is 
maximal in the basal layer, whereas HER2 and 3 are 
predominant in suprabasal layers [2-4]. No epidermal 
expression of HER4 has been reported yet. 
 The relevance of the HER family in keratinocytes is not 
only suggested by the expression of three members, it is also 
sustained by the numerous possible ligands expressed by 
keratinocytes themselves, including TGF, HB-EGF, or 
amphiregulin as ligands of HER1/EGFR [5-7], and also 
heregulins as ligands for HER3 [2, 8]. It is of interest to 
notice that signaling events that depend on the activation of 
HER family members as homodimers or heterodimers are 
not redundant, illustrating by their diversity the significance 
of these receptors signaling pathways. 
 The following paragraphs briefly overview major cell 
functions that are under the control of HER1/EGFR 
signaling in epidermal keratinocytes. 
2.1. HER1/EGFR in Proliferation and Survival of 
Keratinocytes 
 The HER1/EGFR-dependent signaling in keratinocytes 
denotes a pathway that controls proliferation of this  
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epidermal cell type. As a ligand, EGF was identified by its 
activity in the proliferation and maturation of the epidermal 
tissue. Similarly, the production of HER1/EGFR knock-out 
mice exhibiting no expression of the HER1/EGFR revealed, 
among other profound modifications, alterations in the 
characteristics of the epidermis, demonstrating the crucial 
tissue control afforded by the interaction between EGF and 
HER1/EGFR in keratinocytes [9, 10]. In cell culture, the 
requirement for EGF in cultures of keratinocytes has been 
illustrated in both serum-containing model [11] and in 
serum-free conditions [12]. Moreover, the identification of 
culture conditions that allow autocrine growth of human 
keratinocytes have depicted amphiregulin as a secreted 
growth factor in proliferating cultures of keratinocytes, but 
also demonstrated the critical ligand-binding on the 
HER1/EGFR in order to maintain the proliferation of this 
cell type in absence of any added growth factor in culture 
medium [13-15]. However, whereas the addition of EGF 
could not rescue keratinocytes from growth-arrest in 
confluent cultures when the cells are committed towards 
terminal differentiation [16, 17], the addition of EGF to 
those keratinocytes was nonetheless still able to suppress the 
gene expression of early differentiation markers [16]. 
 Downstream to the activation of the tyrosine kinase 
activity in cytoplasmic domain of HER1/EGFR, adapting 
intermediates transduce the signal to Ras and mitogen-
activated protein kinase (MAPK) pathways. Particularly, the 
HER1/EGFR-ERK1/2 MAPK pathway plays a crucial role 
in mediating the proliferative program in keratinocytes. 
Indeed, any interruption of the signaling induced by the 
autocrine growth factors will not only cause the arrest of 
keratinocyte proliferation, it will also induce irreversible 
commitment towards terminal differentiation [18]. This 
observation illustrates the significance of HER1/EGFR in 
keratinocyte cycle progression and thus proliferation [19, 
20]. Consequently, a blockade of HER1/EGFR-dependent 
signaling, either by antagonist antibodies or selective 
inhibitors of kinase activities, induces keratinocyte 
susceptibility to cell death, for instance after a stress-like UV 
exposure [21]. Contrarily, the activation of the HER1/EGFR 
and MAPK pathway protects keratinocytes against the cell 
death that results from culture in suspension [22]. 
 Along with the classical signal transduction cascade 
involving the MAPK ERK1/2 that has been extensively 
studied in many cell types as well as in keratinocytes 
following HER1/EGFR activation [23], the 
phosphatidylinositol 3-kinase (Pi3K) recruitment and 
activation result, through the production of 
phosphoinositides, in the phosphorylation and activation of 
the critical serine-threonine in Akt, a kinase that plays 
pivotal role in cell survival [24]. In addition, the recruitment 
of phospholipase C gamma (PLC) by the activated 
HER1/EGFR receptor is directly responsible for the 
production of diacylglycerol (DAG), a molecule that recruits 
and activates the protein kinase C (PKC), another important 
epidermal signal transducer. Indeed, PKC has been 
exhaustively studied in keratinocytes and its role has been 
demonstrated in the regulation of keratinocyte proliferation, 
as well as in the control of epidermal differentiation [25]. 
 
2.2. HER1/EGFR in Adhesion and Migration of 
Keratinocytes 
 The HER1/EGFR is also involved in the regulation of 
keratinocyte adhesion and migration by its multiple 
interactions with the transmembrane adhesion proteins of the 
integrin family. Integrins are heterodimeric adhesive 
receptors. 
 In keratinocytes, integrins of the 1 subtype organize 
focal adhesion complexes that transmit information as 
intracellular signals and whose activities are modulated by 
EGF-dependent signaling. For instance, Chen and co-
workers have largely illustrated that EGF acts on 1-
integrins in order to enhance the cellular mobility of 
keratinocytes [26]. These observations can be correlated with 
the enhanced integrin expression during epidermal wound 
healing [27], but also with the positive role played by EGF, 
or more physiologically by ligands that bind the 
HER1/EGFR, on the repair mechanisms in the skin and 
epidermis [28]. 
 A second subtype of integrin, the integrin 64, is 
particularly important in the physiology of epidermal 
keratinocytes where it concentrates in hemidesmosomes. It 
has been shown that signaling from integrin 64 functions 
through MAPK and is thus acting closely to the signaling 
induced by the activated HER1/EGFR [29]. Also, signaling 
from the HER1/EGFR through Src kinase family members 
was found to disrupt the function of 64 and lead to 
disassembly of hemidesmosomes and stimulation of 
keratinocyte migration [30]. Very interestingly, 64 is 
further linked to the mitogenic effect of EGF on keratinocyte 
by its compartmentalization into specialized plasma 
membrane called lipid rafts (that will be described below), 
suggesting that such domains are crucial for the normal 
control and function of keratinocytes [31]. Integrin-
dependent phosphorylation of Tyr-845 in HER1/EGFR, a 
tyrosine located in the activation loop of the receptor, may 
occur through Src kinase activity and is a priming event for 
subsequent activation of the HER1/EGFR tyrosine kinase 
activity. This activity is required for the phosphorylation of 
the other tyrosine residues of the receptor [32]. 
 Thus HER1/EGFR activity controls adhesion and 
migration of keratinocytes in collaboration with integrins 
that are normally expressed in the basal epidermal layer. 
Normal commitment of keratinocytes towards differentiation 
is accompanied by the inhibition of integrin expression, but 
an abnormal suprabasal expression of integrins is seen in 
psoriasis. Interestingly, this pathological situation can be 
experimentally mimicked by forcing the suprabasal 
expression of 1 integrin in keratinocytes [33], or by the 
epidermal overexpression of amphiregulin [34], the 
HER1/EGFR ligand that allows autocrine growth of 
keratinocytes in serum-free culture conditions [14]. 
2.3. HER1/EGFR in the Differentiation of Keratinocytes 
 As already mentioned above, the treatment of 
keratinocytes with EGF initiates HER1/EGFR -dependent 
signaling and results in the suppression of the expression of 
certain markers of epidermal differentiation in keratinocytes,  
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namely the suprabasal keratins 1 and 10 [16, 35]. We have 
also reported a similar inhibition of the expression of 
keratins 1 and 10 when signaling is induced in keratinocytes 
by Heregulins that activate the receptors HER2 and HER3 
[2] or by treatment of keratinocytes with HB-EGF [36]. 
Altogether, these reports suggest that signaling through HER 
family rather inhibits some epidermal differentiation; 
however, a few reports have illustrated that high 
concentrations of EGF are able to induce the expression of 
particular markers of epidermal differentiation; especially 
the involucrin expression is enhanced after EGF or HB-EGF 
treatment [36, 37], decoupling EGF-dependent signaling 
from an automatic inhibitory action on the differentiation 
process. 
 The HER1/EGFR is located inside the plasma membrane 
on the cell surface. However the plasma membrane 
environment is currently considered as non homogenous and 
can differentially influence the activity of receptors 
embedded in the membrane. The next part of this review 
intends to characterize specialized plasma membrane 
microdomains. 
3. WHAT DO WE KNOW ABOUT LIPID RAFTS? 
 Within the plasma membrane, the presence of different 
lipid species (glycerophospholipids, sphingolipids, sterols) is 
responsible for important variability in the degree of 
membrane ordering, creating zones where lipids such as 
cholesterol and sphingolipids are not distributed evenly but 
clustered into highly ordered membrane microdomains. This 
phenomenon allows formation of particular membrane areas 
that have been termed “detergent resistant membrane” 
(DRM), “liquid-ordered phase”, or “detergent-insoluble 
glycolipid rich domains” (DIG), depending on the technique 
that has been used for the isolation or identification of such 
microdomains. However, even though the identifying 
techniques were different, researchers studying those 
microdomains realized that they were more or less working 
on similar materials, leading Simons and Ikonen to propose a 
new concept named “lipid rafts” [38]. Thus, according to 
available knowledge, lipid rafts were described as tightly 
packed and highly ordered domains inside the plasma 
membrane. The lipid rafts are containing high concentrations 
of specific lipids (sphingolipids and cholesterol) but are not 
devoid of proteins, localized as transmembrane proteins or 
covalently anchored on the outer or inner surfaces of the 
rafts [39]. Interestingly, enrichment of signaling molecules 
within the lipid rafts domains of the plasma membrane has 
led to the hypothesis that these structures are able to 
maintain preassembled complexes of signaling molecules, 
obviating the need to recruit each partner to the signaling 
structure, therefore increasing the speed of response to 
stimuli. 
 Consequently, lipid rafts have also been proposed as 
molecular platform important for signaling processes, 
despite the fact that a complete and precise definition was 
still lacking. 
 Recently, scientists with various backgrounds met in 
order to adopt a consensus about such a definition. This 
meeting led to the following definition: “Membrane rafts are 
small (10–200 nm), heterogeneous, highly dynamic, sterol- 
and sphingolipid-enriched domains that compartmentalize 
cellular processes. Small rafts can sometimes be stabilized to 
form larger platforms through protein-protein and protein-
lipid interactions” [40]. However, this definition, while 
bringing precision about the fact that it can exist different 
kinds of raft, is still highly theoretical and provides no 
practical or experimental criteria for the identification of 
lipid rafts and their protein components inside the ocean 
membrane. Indeed, on one hand, no specific targeting 
sequence has been discovered yet in identified raft proteins 
(supposing that such sequence would exist), impeding any 
potential prediction of a localization of certain proteins 
inside lipid rafts, on the other hand the identification of 
proteins surely localized in lipid rafts remains highly 
difficult when using techniques such as proteomic or 
membrane fractionation on gradient alone. In addition, 
heterogeneity inside the rafts (both in size and composition) 
enhances the difficulty to precisely define such 
microdomains. 
 In regard of such a difficult definition of lipid rafts, the 
presence of caveolae in plasma membranes is an important 
possibility for confusion as caveolae share similar 
characteristics (resistance to detergent and buoyancy in 
sucrose gradient) with other kinds of lipid rafts. Of course, 
lipid rafts are flat portion of the plasma membrane, whereas 
caveolae form membrane invaginations due to the presence 
of caveolin-1. Despite this difference in morphology, the 
term “caveolae” is sometimes used synonymously with 
“lipid rafts”. Finally, most biochemical/biophysical methods 
that enrich rafts also enrich caveolae. Consequently, “the” 
structural protein of caveolae, caveolin-1, is often 
assimilated to cholesterol-enriched regions, due to its ability 
to directly bind cholesterol [41], enhancing the confusion 
between caveolae and lipid rafts. 
 Since lipid rafts and caveolae (100 nm) are smaller than 
the resolution of light fluorescence microscopy (+/- 200 nm), 
direct observation of lipid rafts does not provide unequivocal 
answer to the question of co-localisation. So lipid rafts are 
currently considered as spatiotemporally regulated dynamic 
lipid-dependent segregation of specific membrane 
components. 
 Recently, Yao et al. have discriminated caveolar 
membranes and non-caveolar lipid microdomains [42]. For 
their investigation, these authors used a modified four-step 
sucrose density gradient, allowing the partition of light low-
density insoluble membrane domains and heavy low-density 
insoluble membrane domains and found that lipid rafts were 
more enriched in cholesterol than caveolae. In addition, the 
protein populations were different since caveolae seemed to 
contain cytoskeletal molecules, whereas lipid rafts contain 
molecules involved in signaling. Surprisingly, flotillin-1, that 
is considered to be more specific for lipid raft domains, was 
rather found in the caveolar portion of the gradient. 
 About the utilization of centrifugation gradients for the 
analysis of lipid rafts, it must be noticed that almost every 
laboratory working on this matter developed its own 
protocol, including or not the use of detergent. One of the 
characteristics of lipid rafts is precisely the resistance of 
those domains to disorganization by detergent. Lipid rafts 
are resistant to Triton X-100, but this detergent appears to 
cluster rafts, creating non pre-existing domains in the plasma 
membrane [43, 44]. Moreover, there exist differences 
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between rafts isolated in the presence of different detergents 
(Triton X-100, Brij 98, Brij 96, Tween 20) [45]. 
 Other protocols using sonication of the cells in pH 11 
sodium carbonate buffer results in rafts fractions that are 
contaminated with other membranes. Methodology plays 
thus a key role in the outcome of any detergent solubilization 
experiments. This is why Macdonald and Pike have 
developed a detergent-free method for lipid raft purification 
[46]. 
 Another experimental way to study the importance of 
lipid rafts in cell physiology is the disorganization of lipid 
rafts by mean of cholesterol extraction. Among the various 
molecules that can be used to deplete membrane cholesterol, 
methyl--cyclodextrin (MCD) appears to be the more 
efficient and widely used tool for the study of lipid rafts. 
MCD is a membrane impermeable, small cyclic 
oligosaccharide with a hydrophobic core that selectively 
extracts cholesterol from the plasma membrane [47, 48]. 
Another widely used molecule is the polyene antibiotic 
filipin from Saccharomyces filipinensis. Filipin forms 
multimeric pack of cholesterol within the plasma membrane, 
inducing structural disorder in the plasma membrane [49, 
50]. 
 In conclusion, although the raft hypothesis is well 
recognized and accepted by use of gradient fractionation, the 
utilization of new techniques, including FRET, atomic-force 
microscopy or single-particle tracking experiments will 
provide clues that lipid rafts are more complex than stable, 
freely diffusing specialized membrane domains made up of 
highly ordered lipids and proteins [51]. 
4. CONTROL OF THE HER1/EGFR BY LIPID RAFTS 
4.1. Localization of HER1/EGFR in Lipid Rafts 
 As we describe above in the first part of this review, 
HER1/EGFR activation and processing are crucial for the 
control of epidermal keratinocytes. Upon ligand binding, the 
HER1/EGFR is believed to move out of the raft portion of 
the plasma membrane, to form dimers and to be internalized 
within clathrin-coated pits as depicted in Fig. (1, for a 
review, see [52]). Whether the activity of HER1/EGFR can 
be regulated by its localization inside membrane lipid rafts 
or outside of these specialized domains has been a matter of 
interest. The plasma membrane cholesterol appears to 
regulate freedom of the HER1/EGFR inside the membrane 
[53] and moreover, the activation of HER1/EGFR by a 
specific ligand can induce coalescence of membrane lipid 
rafts [54]. Thus, the localization of HER1/EGFR and other 
growth factor receptors in the plasma membrane has been 
largely studied. If most growth factor receptors localize to 
the caveolar part of the membrane, HER1/EGFR is a notable 
exception since more than half of the total HER1/EGFR 
population is apparently found in non-caveolar rafts [55] 
whilst smaller percentages are present in caveolae and 
clathrin-coated pits [56]. Yet previous data had initially 
localized HER1/EGFR in caveolae [57]. 
 Different populations of HER1/EGFR may thus reside in 
various areas of the plasma membrane and these 
localizations may be linked to differences both in activation 
and internalization of the receptor. Indeed, accumulating 
evidences have suggested that internalization of the 
HER1/EGFR is performed at the level of clathrin-coated 
pits, as well as at the level of non-coated membrane 
domains, maybe reflecting divergent processing of the 
receptor, depending on its localization in lipid rafts or not 
[58, 59]. 
4.2. Activation of the HER1/EGFR Signaling Pathway 
Following Lipid Rafts Disruption 
 Binding of the HER1/EGFR by its cognate ligands 
induces the activation of the intrinsic tyrosine kinase, 
ensuing receptor autophosphorylation and recruitment/ 
activation of the signal transduction machinery. 
Concurrently, ligand-activated receptors trigger their own 
endocytosis in order to extinguish signaling. Actually 
signaling takes place mostly inside lipid rafts, whereas 
endocytosis occurs mainly at the level of clathrin-coated pits 
where activated receptors are clustered for efficient 
internalization. 
 Several independent investigations have demonstrated 
that the receptor activity of the HER1/EGFR is significantly 
enhanced after the disruption of lipid rafts by cholesterol 
depletion using methyl--cyclodextrin. In addition, a 
concomitant increase in radiolabelled ligand-binding on the 
HER1/EGFR is observed after lipid rafts disruption [55, 60, 
61]. Such an increased binding is likely due to a better 
accessibility of the receptors for the ligand, maybe due to 
some flattening of clathrin-coated pits and caveolae that 
results from the incubation with methyl--cyclodextrin [62-
64] (Fig. 1). 
 Since HER1/EGFR is activated in a ligand-independent 
manner following cholesterol depletion, several different 
mechanisms likely responsible for this activation have been 
proposed. In the peculiar case of HER1/EGFR, lipid raft 
disorganization appears to unmask receptor at the cell 
surface, increasing the number of exposed HER1/EGFR to 
ligand without externalisation of an internal pool of the 
receptor [60]. Some clues concerning the activation of the 
HER1/EGFR following cholesterol depletion have been 
given [65], however we still do not know precisely what 
triggers this activation. Possibly Src kinases could be 
involved since Tyr-845 on the HER1/EGFR is a site known 
to be phosphorylated by pp60
src
 and its phosphorylation 
positioned in the activation loop of the kinase domain is 
associated with stimulated kinase activity of HER1/EGFR 
[66]. Indeed, Tyr-845 is found phosphorylated following 
lipid raft disruption [67], however an inhibition of the Src 
kinases is unable to totally impede HER1/EGFR activation 
[65], strongly suggesting that other mechanisms might be 
involved in ligand-independent HER1/EGFR activation. For 
instance, we could propose that some destabilisation of the 
receptor may occur once HER1/EGFR is localized outside 
lipid rafts due to an unusual molecular environment in the 
plasma membrane. This new environment might allow 
changes in structural conformation of the HER1/EGFR, 
leading to the exposure of the dimerization arm and torsion 
of the cytoplasmic tail. Also, an increased liberty for lateral 
movements of HER1/EGFR in the plasma membrane, or a 
local increase in size of the HER1/EGFR population might 
strongly enhance the frequency of receptors clustering and 
dimers formation. 
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5. THE HER1/EGFR IN LR IN KERATINOCYTE 
 The presence of lipid rafts in the plasma membrane of 
epidermal keratinocytes has been demonstrated and shown to 
rearrange during cell culture. As those microdomains were 
especially reported in transit amplifying keratinocytes [68], 
we postulated an involvement of lipid rafts in the regulation 
of phenotype in the epidermal cells. Indeed, a treatment of 
cultured human keratinocytes with methyl--cyclodextrin for 
1 hour resulted in reduction of the total cholesterol content of 
 
Fig. (1). Comparison between ligand-induced activation of the HER1/EGFR and its activation consecutive to the disruption of lipid 
rafts/caveolae. The HER1/EGFR is located in the lipid rafts/caveolae fraction of the plasma membrane. Upon stimulation with a ligand, the 
receptor forms dimers that migrate outside the lipid rafts/caveolae and are internalized in clathrin-coated pits. Depletion of membrane 
cholesterol induces flattening and disorganization of lipid rafts/caveolae, leading to dimers formation, but not to internalization of the 
HER1/EGFR. 
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cells, as attested by cholesterol assay or filipin staining [37], 
and the prolonged cholesterol depletion maintained by the 
use of lovastatin as an inhibitor of cholesterol synthesis 
resulted in a strongly altered expression of epidermal 
differentiation markers, revealed by suppressed expression 
of keratins 14 and 10, whilst the expression of involucrin 
was accelerated [37]. This alteration was mimicked by 
treatment of keratinocytes with EGF, suggesting that 
activation of HER1/EGFR could be responsible for those 
observations. However, although the HER1/EGFR was 
indeed phosphorylated in those conditions, the specific 
inhibition of the tyrosine kinase activity of the receptor with 
PD153035 did not impede the phenotype alteration obtained 
through cholesterol depletion. Rather, we found that the 
kinase activity of p38 MAPK was required for the observed 
alteration of phenotype [36, 37]. This alteration was further 
demonstrated as resulting in the transient over-expression of 
the heparin-binding EGF-like growth factor (HB-EGF), a 
phenomenon that also depended on the activation of the p38 
MAPK and which may be responsible for inhibition of 
suprabasal keratins and upregulation of involucrin [36]. 
 As previously described in several cell types, as well as 
in normal human keratinocytes [37], we also found the 
HER1/EGFR activated in a ligand-independent manner in 
immortalized HaCaT keratinocytes [69]. Here again, the 
activation of HER1/EGFR by cholesterol depletion was 
followed by phosphorylation of the ERK1/2 MAPK and p38 
MAPK as in normal human keratinocytes [70]. 
 Several points emerge from those studies. First, the 
program of epidermal differentiation in keratinocytes 
appears to be altered upon disruption of cholesterol-enriched 
domains in the plasma membrane. This is due to the 
activation of p38 MAPK. However, even though p38 MAPK 
emerge as a highly significant actor in the response 
developed by keratinocytes towards cholesterol depletion, no 
explanation of mechanisms responsible for its activation has 
been put forward so far. Second, in response to the 
disorganization of cholesterol-enriched domains, 
keratinocytes trigger two apparently opposing reactions: the 
late differentiation process seems started up because the 
expression of involucrin is upregulated, but at the same time, 
the specific HER1/EGFR ligand HB-EGF is produced and 
released in the cellular environment. Thus, cholesterol-
enriched domains (lipid rafts and caveolae, as no distinction 
between them can be made when using MCD) are playing 
major roles in regulation of keratinocyte phenotype (Fig. 2). 
 Because a long-term incubation of keratinocytes with 
MCD is known to induce cell death, likely through 
apoptotic stimulation [71, 72], it is of interest to allow cells 
recovering from shorter (1 hour) cholesterol depletion and 
lipid raft disruption. Indeed, during recovery periods, 
keratinocytes restore normal signalization since 
HER1/EGFR and p38 MAPK phosphorylations disappear, 
although the cellular proliferation is unaffected [70]. 
Interestingly, and despite previous studies have shown the 
inability of cells to internalize HER1/EGFR during lipid raft 
disruption [73], we observed that during the recovery period 
of keratinocytes, a particular internalization of HER1/EGFR 
occurred [70]. This internalization was a phenomenon 
clearly dependent on the activity of p38 MAPK (Fig. 2), 
resembling a process recently described in HeLa cells 
submitted to stressing conditions [74, 75]. 
 
Fig. (2). Fate of the HER1/EGFR following disruption of lipid raft/caveolae. Upon cholesterol depletion by MCD, the HER1/EGFR is 
activated and form dimers that subsequently activate ERK 1/2 and p38 MAPK. During the recovery period, activated p38 MAPK induces 
keratinocytes differentiation [37], HB-EGF shedding [36] and HER1/EGFR internalization through yet undefined structures, leading to 
proteasomal degradation [69]. 
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 Hypothetically, such an internalization of the HER1/EGFR 
following cholesterol depletion and lipid raft disruption 
could be a protective measure taken by keratinocytes in order 
to prevent the stimulation of the receptor through ligand-
binding (e.g. HB-EGF) during the stressful condition i.e. 
membrane fluidization, induced by cholesterol removal [76]. 
This hypothesis is supported on one hand by the observation 
that mechanical scratches in keratinocyte cultures induce 
activation and p38 MAPK-dependent internalization of the 
HER1/EGFR (unpublished data) and on the other hand by 
the detection of HB-EGF expression in stressful conditions 
such as wound healing, oxidative stress, and cholesterol 
depletion [36]. 
 In summary, cholesterol-enriched domains in the plasma 
membrane of epidermal keratinocytes could be central 
platform managing cell signalization in this cell type. Lipid 
rafts and caveolae provide thus protection and alert signals 
towards neighboring cells after stress of the tissue by the 
mean of activation of the HER1/EGFR and consequently p38 
MAPK pathway activation. 
6. CONCLUSION 
 Keratinocytes physiology appears to be modulated by 
events interfering with the integrity/structure of the plasma 
membrane cholesterol-enriched domains commonly named 
lipid rafts and caveolae. Specially the regulation of the 
signaling through the HER1/EGFR appears to be highly 
regulated by its membrane molecular environment. As the 
HER1/EGFR represents maybe the most influent regulator in 
normal and pathological epidermal conditions, the control of 
its interactions within particular plasma membrane domains 
could represent a target for future investigations and 
therapeutics. 
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